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Active Bacterial Core Surveillance (ABCs) Report
Emerging Infections Program Network
Haemophilus influenzae, 2000
ABCs Areas
California (3 county San Francisco Bay area); Connecticut;
Georgia; Maryland; Minnesota; New York (15 county
Rochester/Albany area); Oregon; Tennessee (11 countyarea).
ABCs Population
The surveillance areas represent 33,327,077 persons.
Source: U.S. Bureau of the Census, 2000
ABCs Case Definition
Invasive Haemophilus influenzae (Hi) disease: isolation of
Haemophilus influenzae from normally sterile site in a
resident of a surveillance area in 2000.
ABCs Methodology
Project personnel communicated at least monthly with
contacts in all microbiology laboratories serving acute care
hospitals in their area to identify cases. Standardized case
report forms that include information on demographic
characteristics, clinical syndrome, and outcome of illness
were completed for each identified case. Serotyping was
done on Hi isolates at CDC and state laboratories. Regular
laboratory audits assess completeness of active surveillance
and detect additional cases.
All rates of invasive Hi disease were calculated using U.S.
Bureau of the Census population estimates for 2000. For
national projections, race- and age-specific rates of disease
were applied from the aggregate surveillance areas to the
race- and age-specific distribution of the 2000 U. S.
population. Cases with unknown race were distributed by
area based on reported race distribution for known cases
within the eight age categories.
Reported ABCs Profiles
Race No. (Rate*)
White 315 (1.3)
Black 82 (1.5)
Other 8 (0.2)
Total 405 (1.2)
Unknown race (n=38) distributed among knowns
*Cases per 100,000 population for ABCs areas.
Cases Deaths
Syndrome No. (%*) No. (Rate†)
Meningitis 27 (6.7) 1 (3.8)
Bacteremia w/o focus 158 (39.0) 34 (21.8)
*Percent of cases.
†Deaths per 100 cases with known outcome
Age
(years)
Serotype
b Non-b Non-Type† Unknown
No. (Rate*) No. (Rate) No. (Rate) No. (Rate)
<1 4 (0.9) 10 (2.2) 18 (4.0) 3 (0.7)
1 1 (0.2) 1 (0.2) 5 (1.1) 2 (0.5)
2-4 0 (0.0) 1 (0.1) 1 (0.1) 1 (0.1)
5-17 0 (0.0) 6 (0.1) 10 (0.2) 3 (0.1)
18-34 3 (0.04) 1 (0.01) 12 (0.2) 10 (0.1)
35-49 8 (0.1) 18 (0.2) 20 (0.3) 13 (0.2)
50-64 5 (0.1) 15 (0.3) 32 (0.6) 14 (0.3)
>65 5 (0.1) 35 (0.9) 110 (2.9) 38 (1.0)
Total 26 (0.1) 87 (0.3) 208 (0.6) 84 (0.3)
* Cases per 100,000 population for ABCs areas
† Non-typeable isolates
National Projection for Invasive Disease:
Cases: 3,400 (1.2/100,000)
Deaths: 700 ( 0.2/100,000)
Healthy People 2010 Update:
Invasive Haemophilus influenzae type b disease 
Objective: Decrease the incidence of invasive Haemophilus 
influenzae type b disease to zero cases per 100,000 persons 
less than 5 years of age.
Race 2010 Objective 2000 Rate*
White 0/100,000 —/100,000
Black 0/100,000 —/100,000
Other 0/100,000 —/100,000
Total 0/100,000 0.2/100,000
*Projected cases per 100,000 U.S. population <5 years.
For more information, visit our web site at:
http://www.cdc.gov/abcs
